tiprankstipranks
Advertisement
Advertisement

CRDL Stock Latest News

Cardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
Company AnnouncementsCardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
17d ago
6K
CRDL
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
PremiumCompany Announcements
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
29d ago
6K
CRDL
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
PremiumCompany Announcements
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
1M ago
6K
CRDL
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
PremiumCompany Announcements
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
1M ago
6K
CRDL
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
PremiumThe Fly
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
2M ago
CRDL
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
PremiumCompany AnnouncementsCardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
2M ago
6K
CRDL
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
Premium
Company Announcements
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
2M ago
6K
CRDL
Cardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
Premium
Company Announcements
Cardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
2M ago
6K
CRDL
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
PremiumCompany Announcements
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
2M ago
6K
CRDL
CRDL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CRDL Upcoming Earnings Report: What to Expect?
2M ago
CRDL
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
4M ago
6K
CRDL
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
PremiumCompany Announcements
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
4M ago
6K
CRDL
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
PremiumCompany AnnouncementsCardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
4M ago
6K
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
Premium
Company Announcements
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
5M ago
6K
CRDL
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
Premium
Company Announcements
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
5M ago
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
PremiumCompany Announcements
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
5M ago
CRDL
Cardiol Therapeutics trading resumes
PremiumThe Fly
Cardiol Therapeutics trading resumes
5M ago
CRDL
Cardiol Therapeutics trading halted, news pending
PremiumThe Fly
Cardiol Therapeutics trading halted, news pending
5M ago
CRDL
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis
PremiumCompany Announcements
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis
5M ago
6K
CRDL
Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
PremiumRatingsCardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
6M ago
CRDL
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
Premium
TipRanks Newswire
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
6M ago
CRDL
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
Premium
Company Announcements
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
6M ago
6K
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >